Roche presents new and updated data for Polivy in previously untreated diffuse large B-cell lymphoma at ASH 2022 December 12, 2022January 20, 2023 by / Share This.....LinkedinTwitterFacebookGoogleEmailRelated News: CHMP recommends EU approval of Roche’s Polivy…Roche’s Polivy combination approved by European…FDA accepts supplemental Biologics License…FDA Advisory Committee votes in favour of the…Roche’s Polivy combination reduced the risk of…New data for Roche’s Columvi and Lunsumio presented…
